• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Sonida Senior Living Inc.

    2/26/26 5:04:38 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care
    Get the next $SNDA alert in real time by email
    8-K
    false 0001043000 0001043000 2026-02-26 2026-02-26
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 26, 2026

     

     

    Sonida Senior Living, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   1-13445   75-2678809

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    14755 Preston Road

    Suite 810

    Dallas, Texas

      75254
    (Address of Principal Executive Offices)   (Zip Code)

    Registrant’s Telephone Number, Including Area Code: (972) 770-5600

     

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.01 per share   SNDA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

     

     
     


    INTRODUCTORY NOTE

    As previously announced, on November 4, 2025, Sonida Senior Living, Inc., a Delaware corporation (the “Company” or “SNDA”), SSL Sparti LLC, a Delaware limited liability company and a wholly owned subsidiary of SNDA (“Holdco”), SSL Sparti Property Holdings, Inc. (f/k/a Sparti Merger Sub, Inc.), a Maryland corporation and a wholly owned subsidiary of Holdco and an indirect wholly owned subsidiary of SNDA (“SNDA Merger Sub”), CNL Healthcare Properties, Inc., a Maryland corporation (“CHP”), and CHP Merger Corp., a Maryland corporation and a wholly owned subsidiary of CHP (“CHP Merger Sub”) entered into a definitive agreement and plan of merger (the “Merger Agreement”). The Merger Agreement provides that, among other things and subject to the terms and conditions thereof, (i) on the first closing date, (a) CHP will sell to SNDA Merger Sub equity interests in certain CHP subsidiaries (the “Equity Purchase”) in exchange for shares of common stock, $0.01 par value per share, of SNDA (“SNDA Common Stock”), (b) CHP Merger Sub will merge with and into CHP, with CHP continuing as the surviving entity (the “First Merger”), and (c) CHP will adopt a plan of liquidation substantially concurrently with the effective time of the First Merger (the “First Merger Effective Time”), and (ii) on the second closing date, CHP will merge with and into SNDA Merger Sub (the “Second Merger” and, together with the Equity Purchase and the First Merger, the “Transactions”), whereupon the separate existence of CHP will cease, with SNDA Merger Sub continuing as the surviving entity of the Second Merger and an indirect wholly owned subsidiary of SNDA.

     

    Item 5.07.

    Submission of Matters to a Vote of Security Holders.

    On February 26, 2026, the Company held a special meeting of stockholders of the Company (the “SNDA Special Meeting”) to consider and vote upon the following matters: (i) a proposal to approve and adopt an amendment to the Amended and Restated Certificate of Incorporation of the Company, as amended (the “SNDA Charter”), to increase the number of shares of SNDA Common Stock that the Company is authorized to issue from 30,000,000 to 100,000,000 shares (the “Authorized Share Increase Proposal”), (ii) a proposal to approve the issuance of shares of SNDA Common Stock to (a) holders of CHP common stock pursuant to the Merger Agreement and (b) certain affiliates of Conversant Capital, LLC (“Conversant”) and Silk Partners, LP (“Silk”), two of the Company’s largest beneficial owners, in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Stock Issuance Proposal”), (iii) a proposal to approve and adopt amendments to the SNDA Charter to provide for (a) procedures regarding the advance notice of stockholder nominations for the election of directors and other business to be brought before any meeting of stockholders to be as set forth in the Second Amended and Restated Bylaws of SNDA, as amended (the “Advance Notice Proposal”), and (b) customary limitations on indemnification and expense advancement for directors and officers (the “Indemnification Proposal”), and (iv) a proposal to adjourn the SNDA Special Meeting to another time or place, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the SNDA Special Meeting to approve the Authorized Share Increase Proposal or the Stock Issuance Proposal (the “SNDA Adjournment Proposal”). Prior to the SNDA Special Meeting, the Company delivered a definitive joint proxy statement/prospectus (the “Joint Proxy Statement/Prospectus”) to its stockholders describing the SNDA Special Meeting, the Authorized Share Increase Proposal, the Stock Issuance Proposal, the Advance Notice Proposal, the Indemnification Proposal, the SNDA Adjournment Proposal, the Transactions, and related information. The Joint Proxy Statement/Prospectus was filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective on January 6, 2026.

    As disclosed in the Joint Proxy Statement/Prospectus, as of the close of business on December 30, 2025, the record date for the SNDA Special Meeting, there were 18,769,604 outstanding shares of SNDA Common Stock and 41,250 outstanding shares of Series A Preferred Stock, par value $0.01 per share, of SNDA (“SNDA Preferred Stock” and together with SNDA Common Stock, the “SNDA Stock”) entitled to an aggregate number of 1,281,205 votes on the proposals considered at the SNDA Special Meeting. Each holder of SNDA Common Stock was entitled to cast one (1) vote on each matter brought before the SNDA Special Meeting for each share of SNDA Common Stock that such holder owned of record as of the record date. Each holder of SNDA Preferred Stock was entitled to a number of votes equal to the number of shares of SNDA Common Stock to which such shares of SNDA Preferred Stock could be converted as of the record date for the SNDA Special Meeting on all matters to be acted upon at the SNDA Special Meeting, voting together with the holders of SNDA Common Stock as a single class. As further disclosed in the Joint Proxy Statement/Prospectus, on November 4, 2025, certain affiliates of Conversant that hold shares of SNDA Stock representing approximately 52.6% of the votes entitled to be cast by the holders of outstanding shares of capital stock of SNDA entered into a Voting Agreement with CHP, whereby they agreed, among other things, to vote their shares of SNDA Stock in favor of the Authorized Share Increase Proposal, the Stock Issuance Proposal and the SNDA Adjournment Proposal.


    A total of 18,227,189 votes, representing approximately 91% of the eligible votes of SNDA Stock entitled to vote at the SNDA Special Meeting, were present in person or by proxy, constituting a quorum to conduct business.

    At the SNDA Special Meeting, the Company’s stockholders approved (i) the Authorized Share Increase Proposal, (ii) the Stock Issuance Proposal, (iii) the Advance Notice Proposal, and (iv) the Indemnification Proposal.

    The final voting results for the proposals voted on at the SNDA Special Meeting are set forth below. For more information on the Authorized Share Increase Proposal, the Stock Issuance Proposal, the Advance Notice Proposal, and the Indemnification Proposal, see the Joint Proxy Statement/Prospectus filed by SNDA pursuant to Rule 424(b)(3) (Registration No. 333-292187) with the SEC on January 6, 2026.

     

    1.

    Authorized Share Increase Proposal - Approval and adoption of an amendment to the SNDA Charter to increase the number of shares of SNDA Common Stock that the Company is authorized to issue from 30,000,000 to 100,000,000 shares.

     

    For

     

    Against

     

    Abstain

    18,060,465

      162,290   4,434

     

     

     

     

     

    The number of votes cast in favor of the Authorized Share Increase Proposal by the holders of outstanding shares of SNDA Stock entitled to vote thereon voting together as a single class, and with respect to the SNDA Preferred Stock, on an as-converted basis, exceeded the number of votes cast by such holders against the Authorized Share Increase Proposal (with abstentions having no effect on the Authorized Share Increase Proposal).

     

    2.

    Stock Issuance Proposal - Approval of the issuance of shares of SNDA Common Stock to (a) holders of shares of common stock of CHP in connection with the Merger Agreement and (b) to certain investors affiliated with Conversant and Silk pursuant to the investment agreements.

     

    For

     

    Against

     

    Abstain

    17,821,993

      2,699   3,736

     

     

     

     

     

    A majority of the votes cast by the holders of outstanding shares of SNDA Stock entitled to vote thereon voting together as a single class, and with respect to the SNDA Preferred Stock, on an as-converted basis, were voted in favor of the Stock Issuance Proposal (with abstentions having no effect on the Stock Issuance Proposal).

     

    3(a).

    Advance Notice Proposal - Approval and adoption of an amendment to the SNDA Charter to provide for procedures regarding advance notice of stockholder nominations for the election of directors and other business to be brought before any meeting of stockholders to be as set forth in SNDA’s Bylaws.

     

    For

     

    Against

     

    Abstain

    17,796,027

      32,386   15

     

     

     

     

     

    The Advance Notice Proposal received the affirmative vote of at least two-thirds of the voting power of all issued and outstanding voting stock of the Company entitled to vote generally in the election of directors (with abstentions having the same effect as a vote “AGAINST” the Advance Notice Proposal).

     

    3(b).

    Indemnification Proposal - Approval and adoption of an amendment to the SNDA Charter to provide for customary limitations on indemnification and expense advancement for directors and officers.

     

    For

     

    Against

     

    Abstain

    17,770,707

      39,317   18,404

     

     

     

     

     


    The Indemnification Proposal received the affirmative vote of at least two-thirds of the voting power of all issued and outstanding voting stock of the Company entitled to vote generally in the election of directors (with abstentions having the same effect as a vote “AGAINST” the Indemnification Proposal).

     

    4.

    SNDA Adjournment Proposal - Because there were sufficient votes to approve the Authorized Share Increase Proposal and the Stock Issuance Proposal, no proposal to adjourn the SNDA Special Meeting was made.

    No other business properly came before the SNDA Special Meeting.

     

    Exhibit
    No.
      Description
    104   Cover Page Interactive Date File-formatted as Inline XBRL

    *  *  *  *  *  *

    Cautionary Note Regarding Forward-Looking Statements

    This communication contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements that include the words “expect,” “will,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “could,” “should,” “anticipate” and similar statements of a future or forward-looking nature. The forward-looking statements, are subject to certain risks and uncertainties, and actual results, events and financial condition could materially differ from those indicated in the forward-looking statements, including, among others, (1) the termination of or occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement or the inability to complete the proposed transaction on the anticipated terms or by the end of the outside date of the Merger Agreement, (2) the inability to complete the proposed transaction due to the failure to satisfy all of the conditions to closing in a timely manner or at all, including the failure to obtain the requisite stockholder approvals or to obtain the equity financing contemplated by the Merger Agreement (the “Equity Financing”), or the risk that a regulatory approval that may be required for the proposed transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated, (3) costs related to the proposed transaction, including costs with respect to the Equity Financing, (4) the diversion of management’s time and attention from ordinary course business operations to completion of the proposed transaction and integration matters, (5) the risk of litigation action related to the proposed transaction, (6) such other economic or other conditions in the markets CHP or Sonida are engaged in, (7) the risks, uncertainties and factors set forth under “Item. 1A. Risk Factors” in Sonida’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 17, 2025, and as such factors may be updated from time to time in Sonida’s other filings with the SEC, and (8) the risks, uncertainties and factors set forth under “Item. 1A. Risk Factors” in CHP’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 5, 2025, and as such factors may be updated from time to time in CHP’s other filings with the SEC, which filings are accessible on the SEC’s website at www.sec.gov. This list of factors is not intended to be exhaustive. Forward-looking statements only speak as of the date of this communication, and neither CHP nor Sonida assumes any obligation to update any written or oral forward-looking statement made by either Sonida or on its behalf or CHP or on its behalf as a result of new information, future events or other factors, except as required by law.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

            SONIDA SENIOR LIVING INC.
    Date: February 26, 2026    
            By:  

    /s/ Brandon M. Ribar

        Name:   Brandon M. Ribar
        Title:   Chief Executive Officer and President
    Get the next $SNDA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNDA

    DatePrice TargetRatingAnalyst
    1/9/2026Neutral
    Robert W. Baird
    12/13/2024$25.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $SNDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sonida to Participate in Citi's 2026 Global Property CEO Conference

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in senior living communities, announced today that Brandon Ribar, President & Chief Executive Officer, Kevin Detz, Chief Financial Officer and Max Levy, Chief Investment Officer, will participate in Citi's 2026 Global Property CEO Conference on Monday, March 2nd through Wednesday, March 4th at the Diplomat Resort & Spa Hollywood in Florida. Management will be available for one-on-one meetings with institutional investors during the conference. To schedule a meeting, please contact your bank representative. In addition, Mr. Ribar is scheduled to participate in a moderated roundtable

    2/25/26 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living to Participate in the Morgan Stanley 9th Annual CRE Conference

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in senior living communities, announced today that Brandon Ribar, President & Chief Executive Officer, Kevin Detz, Chief Financial Officer and Max Levy, Chief Investment Officer, will participate in Morgan Stanley's Annual Commercial Real Estate Conference on Wednesday, February 18th and Thursday, February 19th at the Morgan Stanley Headquarters in New York City. Management is available for one-on-one meetings with institutional investors during the conference. To schedule a meeting, please contact your bank representative. About Sonida Dallas-based Sonida Senior Living, Inc. is

    2/5/26 8:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces $900 Million of Permanent Debt Financing Commitments in Connection with CNL Healthcare Properties, Inc. Strategic Merger

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in senior living communities, announced today that in connection with the previously announced definitive merger agreement (the "Merger Agreement") with CNL Healthcare Properties, Inc. ("CHP"), Sonida has obtained committed permanent debt financing ("Permanent Facilities") of $900 million, with a $350 million accordion feature that allows Sonida to increase the facilities up to $1.25 billion. As previously communicated on November 5, 2025, Sonida will acquire 100% of the outstanding common stock of CHP for stock and cash consideration valued at approximately $1.8 billion. At the time

    1/5/26 8:05:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird initiated coverage on Sonida Senior Living

    Robert W. Baird initiated coverage of Sonida Senior Living with a rating of Neutral

    1/9/26 9:07:37 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Morgan Stanley initiated coverage on Sonida Senior Living with a new price target

    Morgan Stanley initiated coverage of Sonida Senior Living with a rating of Equal-Weight and set a new price target of $25.00

    12/13/24 8:22:29 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Ribar Brandon bought $98,668 worth of shares (4,000 units at $24.67), increasing direct ownership by 1% to 327,176 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    5/23/25 9:47:19 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Director Simanovsky Michael bought $897,835 worth of shares (42,111 units at $21.32) (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    1/13/25 2:06:54 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    President & CEO Ribar Brandon bought $90,720 worth of shares (4,000 units at $22.68), increasing direct ownership by 1% to 315,469 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    11/19/24 4:47:54 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    SEC Filings

    View All

    SEC Form 8-K filed by Sonida Senior Living Inc.

    8-K - SONIDA SENIOR LIVING, INC. (0001043000) (Filer)

    2/26/26 5:04:38 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    SEC Form 8-K filed by Sonida Senior Living Inc.

    8-K - SONIDA SENIOR LIVING, INC. (0001043000) (Filer)

    2/23/26 5:26:57 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    SEC Form 425 filed by Sonida Senior Living Inc.

    425 - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    2/13/26 4:06:48 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Ribar Brandon covered exercise/tax liability with 809 shares and returned 14,657 shares to the company, decreasing direct ownership by 5% to 311,710 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    9/10/25 7:51:38 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    VP & Chief Accounting Officer Cober Timothy covered exercise/tax liability with 187 shares, decreasing direct ownership by 0.46% to 40,774 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    7/23/25 4:52:33 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Director Zibel Elliot R was granted 2,985 shares, increasing direct ownership by 35% to 11,608 units (SEC Form 4)

    4 - SONIDA SENIOR LIVING, INC. (0001043000) (Issuer)

    6/12/25 8:01:52 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    $SNDA
    Financials

    Live finance-specific insights

    View All

    $SNDA
    Leadership Updates

    Live Leadership Updates

    View All

    $SNDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Sonida Senior Living Announces Third Quarter 2025 Results

    Sonida Senior Living, Inc. (the "Company," "Sonida," "we," "our," or "us") (NYSE:SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025. "In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and strong results in the acquisition portfolio," said Brandon Ribar, President and CEO. "In the same-store portfolio, occupancy achieved its highest levels post-Covid at 87.7%, with end of October spot occupancy reaching 89.0%. Execution on our acquisition strategy continued in September with the addition of a high-quality senior housing community in the D

    11/10/25 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator

    2026E Normalized FFO Accretion of 28% to 62% Based on an Asymmetric Collar with Substantial Near-Term and Future Synergies Strengthens Balance Sheet Through Immediate Deleveraging and Significantly Deepens Access to Capital Transaction Funded with 66% Stock and 34% Cash; Financing for Cash Portion is Committed with Debt Financing from RBC and BMO and Equity Commitments from Sonida's Two Largest Shareholders Creates Eighth Largest Owner of U.S. Senior Living Assets1 Sonida President & CEO Brandon Ribar and Existing Sonida Management Team to Lead Combined Company Sonida Provides Highlights of Preliminary Q3'25 Results Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a

    11/5/25 7:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Announces Third Quarter 2025 Earnings Release Date and Conference Call

    Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner, operator and investor in communities and services for seniors, today announced that it will issue its third quarter 2025 earnings results before the market opens for trading on Monday, November 10, 2025. The Company will then host a conference call and webcast to review its financial performance and operating results at 11:00 a.m. Eastern Time. The dial-in number for the conference call is (800) 715-9871 (or +1 (646) 307-1963 for international callers), and the participant passcode is 4619110. A live webcast can be accessed here. All participants are asked to register and connect 10 minutes prior to the s

    10/30/25 8:15:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Enhances Executive Team and Board to Support Company Growth

    Max Levy appointed Chief Investment Officer in newly created role Lilly H. Donohue, a long-time senior living industry executive, to join Board of Directors Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE:SNDA), a leading owner-operator and investor in communities and services for seniors, today announced the appointment of Max Levy to the newly created role of Chief Investment Officer ("CIO"). In addition, the Company also announced today that Lilly H. Donohue will be appointed to the Board. As CIO and a member of the executive committee, Mr. Levy, who is transitioning to Sonida from his role as a Principal at Conversant Capital ("Conversant"), the Company's largest shar

    5/10/24 5:30:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer

    Expands Sonida's Leadership Team with Robust Clinical Operations Expertise Sonida Senior Living, Inc. (the "Company" or "Sonida Senior Living") (NYSE:SNDA), a leading owner-operator of senior living communities and services, announced the appointment of Tabitha Obenour as Vice President and Chief Clinical Officer, effective November 1, 2023. Obenour joins Sonida from senior living provider Enlivant where she served as the company's Vice President of Clinical Quality and Compliance. "As our company continues to look for growth opportunities, operational excellence and resident care remain our highest priorities. A clinical leader with 20 years' experience, Tabitha has a deep understandin

    11/3/23 8:49:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Sonida Senior Living Announces Leadership Transition

    CEO Kim Lody to step down after eight years with the Company Brandon Ribar promoted from COO to CEO Sonida Senior Living, Inc. (the "Company" or "Sonida") (NYSE:SNDA), one of the nation's leading senior living owner-operators, announced that Kimberly S. Lody has decided to step down after an eight-year tenure with the Company, including approximately three and a half years as Chief Executive Officer (CEO). In accordance with the Company's succession plan, Brandon M. Ribar, the Company's Chief Operating Officer (COO), has been appointed President and CEO, effective September 2, 2022. Lody will continue to serve in her current role through September 2, 2022, to ensure a smooth transition. Ri

    8/4/22 5:00:00 AM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    10/17/24 5:33:31 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    8/21/24 7:18:19 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sonida Senior Living Inc.

    SC 13D/A - SONIDA SENIOR LIVING, INC. (0001043000) (Subject)

    8/19/24 4:26:52 PM ET
    $SNDA
    Hospital/Nursing Management
    Health Care